Page last updated: 2024-10-23

aspirin and Pulmonary Arterial Remodeling

aspirin has been researched along with Pulmonary Arterial Remodeling in 6 studies

Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.

Research Excerpts

ExcerptRelevanceReference
" The goal of this study was to encapsulate Aspirin-Triggered Resolvin D1 (AT-RvD1) into a degradable biomaterial in order to elucidate the effects of sustained, localized delivery in a model of sterile inflammation."3.85Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling. ( Botchwey, EA; Olingy, CE; San Emeterio, CL; Sok, MCP; Tria, MC, 2017)
" This study aimed to evaluate the effects of long-term administration of losartan, aspirin, and atorvastatin on vascular remodeling in juvenile spontaneously hypertensive rats (SHRs)."1.91Effects of Long-Term Intervention with Losartan, Aspirin and Atorvastatin on Vascular Remodeling in Juvenile Spontaneously Hypertensive Rats. ( Dong, B; Dong, S; Li, L; Liu, Q; Shen, J; Yang, K; Zhao, Y; Zhou, X; Zhu, D, 2023)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Liu, Q1
Dong, S1
Zhou, X1
Zhao, Y1
Dong, B1
Shen, J1
Yang, K1
Li, L1
Zhu, D1
Huang, N1
Zhu, TT1
Liu, T1
Ge, XY1
Wang, D1
Liu, H2
Zhu, GX1
Zhang, Z1
Hu, CP1
Fisher, CL1
Demel, SL1
Tara, S1
Kurobe, H1
de Dios Ruiz Rosado, J1
Best, CA1
Shoji, T1
Mahler, N1
Yi, T1
Lee, YU1
Sugiura, T1
Hibino, N1
Partida-Sanchez, S1
Breuer, CK1
Shinoka, T1
Gao, H1
Cheng, Y1
Zong, L1
Huang, L1
Qiao, C1
Li, W1
Gong, B1
Hu, J1
Wang, X1
Zhao, C1
Sok, MCP1
Tria, MC1
Olingy, CE1
San Emeterio, CL1
Botchwey, EA1

Reviews

1 review available for aspirin and Pulmonary Arterial Remodeling

ArticleYear
Nonsteroidal Anti-Inflammatory Drugs: A Potential Pharmacological Treatment for Intracranial Aneurysm.
    Cerebrovascular diseases extra, 2019, Volume: 9, Issue:1

    Topics: Animals; Aspirin; Cerebral Arteries; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dilatat

2019

Other Studies

5 other studies available for aspirin and Pulmonary Arterial Remodeling

ArticleYear
Effects of Long-Term Intervention with Losartan, Aspirin and Atorvastatin on Vascular Remodeling in Juvenile Spontaneously Hypertensive Rats.
    Molecules (Basel, Switzerland), 2023, Feb-15, Volume: 28, Issue:4

    Topics: Animals; Antihypertensive Agents; Aspirin; Atorvastatin; Blood Pressure; Collagen; Hypertension; Int

2023
Aspirin ameliorates pulmonary vascular remodeling in pulmonary hypertension by dampening endothelial-to-mesenchymal transition.
    European journal of pharmacology, 2021, Oct-05, Volume: 908

    Topics: Animals; Aspirin; Endothelium; Epithelial-Mesenchymal Transition; Hypertension, Pulmonary; Rats; Sma

2021
Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model.
    Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:9

    Topics: Absorbable Implants; Animals; Aspirin; Blood Vessel Prosthesis; Cell Proliferation; Cilostazol; Dise

2015
Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2017, Volume: 39, Issue:1

    Topics: Animals; Aspirin; Blood Pressure; Cyclooxygenase Inhibitors; Flavonoids; Hypertension, Pulmonary; Hy

2017
Aspirin-Triggered Resolvin D1-modified materials promote the accumulation of pro-regenerative immune cell subsets and enhance vascular remodeling.
    Acta biomaterialia, 2017, 04-15, Volume: 53

    Topics: Animals; Aspirin; Biocompatible Materials; Cytokines; Docosahexaenoic Acids; Drug Delivery Systems;

2017